Future studies should also aim at characterizing the protein complexes engaged by PAX8 in different contexts (RCC vs. Ovarian and normal vs. cancer) in order to provide a rational for novel drugs that can inhibit the function of PAX8 in cancer cells. Here, PAX8 is linked to renal cell carcinoma.